Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis.

Int J Neuropsychopharmacol · 2022 · PMC9593219 · PMID 35641112

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The aripiprazole group showed a greater increase in the proportion of participants with MetS (Δ9.2%, P = .027), whereas this increment in the risperidone group (Δ4.3%, P > .05) did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.